Floatz logo

Prednisone

T-Cell/Histiocyte Rich Large B Cell Lymphoma

Ruijin HospitalSmall moleculePhase 2/3Active
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
57/ 100
Competitive Position
81/ 100

Competitive context

31 Active assets in the T-Cell/Histiocyte Rich Large B Cell Lymphoma cohort.

Asset / SponsorPhaseRating
Vincristine Sulfate
Northwestern University
Phase 2/3BB
Adriamycin
Ruijin Hospital
Phase 2/3BB
Cyclophosphamide
Ruijin Hospital
Phase 2/3BB
Rituximab
Ruijin Hospital
Phase 2/3BB
Obinutuzumab
National Cancer Institute (NCI)
Phase 2B

View all 32 →

Same molecule, other indications

Prednisone is also rated in:

B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative · Phase 3
74 / 100
View asset →
diffuse large B-cell lymphomaActive
BBB
Indicative · Phase 4
74 / 100
View asset →
peripheral T-cell lymphoma, not otherwise specifiedActive
BBB
Indicative · Phase 4
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →